Wiki
Casinos
Casino reviews A–Z
Sunday, November 22, 2026 Canada
Novello Desserts

Food, health and everyday life in Canada.

Health

Lancet retracts 2006 study linking infant death to codeine in breast milk

The journal says omissions of toxicological data in the 2006 case report constitute falsification.

AO
Lancet retracts 2006 study linking infant death to codeine in breast milk
Photo: Wikimedia Commons

TORONTO · The Lancet has retracted a 2006 Canadian study that claimed a baby died from codeine passed through breast milk, stating that omissions of key data amounted to falsification. The journal announced the retraction of the paper by Gideon Koren, the founder of the now-closed Motherisk lab at Toronto's Hospital for Sick Children. The decision follows a formal investigation by the hospital's research integrity office. The study had been a cornerstone of global guidance on breastfeeding and pain management for nearly two decades.

The case report focused on the 2005 death of an infant in Ontario. It concluded the mother's use of the painkiller Tylenol 3, which contains codeine, led to a fatal amount of morphine passing to her son through breast milk. Koren maintained for years that the case proved maternally ingested codeine could kill breastfeeding babies, a claim other experts repeatedly questioned. The Lancet's retraction notice said the hospital's investigation found the omission of material toxicological data, including the infant's blood codeine levels, constituted falsification.

"The omitted findings left readers without the information necessary to assess the publication's conclusion," the journal's notice stated. It also said authorship and ethical concerns could not be fairly investigated because meaningful participation from Koren was unlikely. A SickKids spokesperson said the hospital takes all matters of research integrity seriously and its inquiry confirmed the omissions were falsification under its research policy. The hospital declined to provide further details, citing the confidential nature of such inquiries.

READ MORE: Northern Ontario First Nations face far higher rates of chronic disease, early death

READ MORE: Maple report finds Canadians carry hidden burden of care coordination

Dr. David Juurlink, a Toronto pharmacologist and longtime critic of the study, said the retraction was long overdue. "This paper is the cornerstone of an entire field of pediatric pharmacology and toxicology that, honestly, should not exist," Juurlink said. He argued the paper's narrative has harmed postpartum care by causing women taking opioids to avoid breastfeeding. "It has caused women taking opioids to forgo breastfeeding, thereby depriving infants of the benefits of breastfeeding, which are numerous," he said.

Juurlink expressed surprise at how long it took for the retraction to occur. "It took investigative journalism to cast a light on the institutional failures that kept this paper alive for 20 years," he said. The Lancet had placed an expression of concern on the paper in February following a New Yorker investigation and new allegations. This marks another setback for Koren, who gave up his Ontario medical licence after the Motherisk lab was shut down in 2019. The Motherisk lab used hair-strand testing for drugs and alcohol, methods later deemed unreliable by a provincial review. Those tests were used as evidence in thousands of child protection cases across Canada before the lab was closed. The retraction of the 2006 study brings renewed scrutiny to Koren's work and its lasting impact on medical practice and families.

With files from CBC News

AO
Health Reporter
Amara Okafor

Amara Okafor covers health, medical research and public health in Canada for Novello Desserts.